The Wellsmont Group has the ability to identify and propose integrative synergies across IVD diagnostics and molecular technologies that create sustainable advantages for our client’s solutions in personalized medicine.
We work with the client’s key stakeholders and project teams to review the company’s solution against unmet needs in healthcare. This includes alignment against stated unmet needs articulated from online interviews and webinars with key opinion leaders and current published literature. As appropriate, we will identify gaps in addressing unmet needs and provide recommendations to address these gaps.
The strength of clinical evidence is reviewed with the client’s key medical leaders and scientists and we can proposed additional strategies to improve the strength of the client’s clinical evidence.
Working with the client’s key stakeholders, we will review the solution in the context of current medical guideline practice and competitive alternatives. Additional strategies can be recommended to improve solution offering in terms of value, clinical utility, and competitive effectiveness.
Our value-added services include:
• Strategy review and development
• Competitive landscape assessment
• Evidence generation plans
• Literature review, analysis and evidence synthesis
• Publication and communication strategy
• KOL and collaborator engagement and management
• Strategies to enhance clinical and economic value
• Strategies to identify and integrate complementary technologies
• Pre- and post-commercialization activity support
• Recommendations on strategic collaborations, partnerships and acquisitions to enhance the client’s solution in personalized and precision medicine
Learn more about our Consulting Services.
Contact us to let us know how we can help you.